Review heart-failure prognosis context using NYHA class, ejection fraction, comorbidities, natriuretic-peptide level, and device status in an educational worksheet.
This page provides a simplified educational heart-failure prognosis worksheet using several common context factors such as NYHA class, ejection fraction, age, natriuretic peptide level, comorbidities, and device therapy. It is meant to show how overall context can change as those factors change.
The page is not a validated survival model. It does not reproduce the Seattle Heart Failure Model, MAGGIC, or any transplant/LVAD selection score, and it should not be treated as a precise forecast for an individual patient.
Use it only as a discussion aid and keep real prognostic decisions anchored in clinician assessment, named models, and heart-failure specialist review.
A simplified estimate can help explain why worsening symptoms, low EF, recurrent admissions, CKD, or elevated natriuretic peptides often trigger closer specialist review.
Its value is educational. It should not replace SHFM, MAGGIC, or clinician-led prognosis review.
Simplified educational risk layering: Broad prognosis context from: Factors include: - EF adjustment - Age adjustment - Diabetes and CKD - BNP / NT-proBNP range - Device context This page intentionally stops at worksheet context and does not generate a validated individualized survival percentage or median-survival forecast.
Result: Higher symptom-burden context with reduced EF and elevated natriuretic-peptide context
This profile shows several broad adverse context flags on the worksheet. The page is showing prognosis context only and does not replace a validated model or clinician-led interpretation.
This page is a simplified educational worksheet that shows how broad prognostic factors can change heart-failure context.
It is not a validated survival model, not a transplant or LVAD triage tool, and not a substitute for SHFM, MAGGIC, or clinician-led prognosis review.
Use it to support a broad educational discussion about why symptom burden, EF, natriuretic peptides, comorbidities, and device therapy matter, while keeping real prognostic decisions anchored in validated models and specialist care.
Last updated:
This page is a site-defined heart-failure context worksheet. It groups symptom burden, EF range, natriuretic-peptide context, device status, and a few comorbidity markers into broad educational context flags instead of calculating a validated survival percentage.
It is intentionally not a reproduction of SHFM, MAGGIC, or an advanced-therapy referral model. The purpose is explanation and context only, while real prognosis work stays anchored in validated models, clinician review, and current heart-failure guidelines.
Individual predictions have substantial uncertainty. Even validated models are only estimates, and this page is simpler than those models, so it should be treated as context rather than as a direct prediction.
Yes. Guideline-directed therapy, device optimization, revascularization, arrhythmia control, and successful treatment of reversible contributors can all improve trajectory.
Those decisions require specialist evaluation and are not something this page can determine. Advanced-heart-failure referral usually depends on symptoms, admissions, objective exercise data, hemodynamics, and response to therapy.
The trajectory can differ, and preserved EF does not automatically mean low risk. This page is a broad educational estimator and does not model every phenotype accurately.
Both matter clinically, but this page only uses broad BNP ranges as a rough context signal. Real interpretation depends on obesity, kidney function, rhythm, and the overall clinical picture.
No. It is not a validated end-of-life or treatment-limitation tool.